整合全基因组信息与可穿戴设备数据探索焦虑及抗抑郁药与脉率变异性的关联
研究从All of Us研究计划选取920名有全基因组测序、Fitbit和电子健康记录数据的个体(61,333个数据点),分析焦虑多基因风险评分(PRS)和抗抑郁药暴露与24小时脉率变异性(SDANN)的关联。焦虑PRS与SDANN降低独立相关(beta=-0.08,p=0.003),文拉法辛、安非他酮、三环类、SSRIs和SNRIs均与SDANN降低相关。单样本孟德尔随机化提示焦虑对SDANN有因果性负向效应(beta=-2.22,p=0.03)。
要点
- 焦虑PRS与SDANN降低独立相关(beta=-0.08,p=0.003)。
- 文拉法辛、安非他酮、三环类、SSRIs和SNRIs与SDANN降低相关。
- 单样本孟德尔随机化提示焦虑对SDANN有因果性负向效应(beta=-2.22,p=0.03)。
核心结论
- 焦虑和抗抑郁药与脉率变异性降低独立相关,焦虑似乎对脉率变异性降低发挥因果效应。
- 这些观察性发现为焦虑对脉率变异性的影响提供了见解。
研究设计与样本
- 从All of Us研究计划选取有全基因组测序、Fitbit和电子健康记录数据的个体(N=920;61,333个数据点)。
- 焦虑PRS采用PRS-CS方法,基于UK Biobank、FinnGen和Million Veterans Program三大队列焦虑全基因组关联研究的荟萃分析(NTotal=364,550)推导。
- 脉率变异性以24小时脉率测量中平均五分钟脉搏波间期的标准差(SDANN)估计。
- 抗抑郁药暴露定义为PRV测量时电子健康记录中存在活跃的抗抑郁药处方。
- 采用单样本孟德尔随机化评估焦虑对PRV的潜在因果效应。
主要发现
- 焦虑PRS与SDANN降低独立相关(beta=-0.08;p=0.003)。
- 在测试的八种抗抑郁药和四类药物中,文拉法辛(beta=-0.12,p=0.002)和安非他酮(beta=-0.071,p=0.01)与SDANN降低相关。
- 三环类抗抑郁药(beta=-0.177,p=0.0008)、选择性5-羟色胺再摄取抑制剂(beta=-0.069;p=0.0008)和5-羟色胺和去甲肾上腺素再摄取抑制剂(beta=-0.16;p=2×10-6)与SDANN降低相关。
- 单样本孟德尔随机化提示焦虑对SDANN有负向效应(beta=-2.22,p=0.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study explores the genetic and epidemiologic correlates of long-term photoplethysmography-derived pulse rate variability (PRV) measurements with anxiety disorders. Individuals with whole-genome sequencing, Fitbit, and electronic health record data (N = 920; 61,333 data points) were selected from the All of Us Research Program. Anxiety polygenic risk scores (PRS) were derived with PRS-CS after meta-analyzing anxiety genome-wide association studies from three major cohorts- UK Biobank, FinnGen, and the Million Veterans Program (NTotal =364,550). PRV was estimated as the standard deviation of average five-minute pulse wave intervals over full 24-hour pulse rate measurements (SDANN). Antidepressant exposure was defined as an active antidepressant prescription at the time of the PRV measurement in the EHR. Anxiety PRS and antidepressant use were tested for association with daily SDANN. The potential causal effect of anxiety on PRV was assessed with one-sample Mendelian randomization (MR). Anxiety PRS was independently associated with reduced SDANN (beta = -0.08; p = 0.003). Of the eight antidepressant medications and four classes tested, venlafaxine (beta = -0.12, p = 0.002) and bupropion (beta = -0.071, p = 0.01), tricyclic antidepressants (beta = -0.177, p = 0.0008), selective serotonin reuptake inhibitors (beta = -0.069; p = 0.0008) and serotonin and norepinephrine reuptake inhibitors (beta = -0.16; p = 2×10-6) were associated with decreased SDANN. One-sample MR indicated an inverse effect of anxiety on SDANN (beta = -2.22, p = 0.03). Anxiety and antidepressants are independently associated with decreased PRV, and anxiety appears to exert a causal effect on reduced PRV. Those observational findings provide insights into the impact of anxiety on PRV.
引用
- Friligkou E, Koller D, Pathak GA, et al. Integrating genome-wide information and wearable device data to explore the link of anxiety and antidepressants with pulse rate variability. Mol Psychiatry. 2024. PMID: 39558002. doi:10.1038/s41380-024-02836-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。